Search
Collplant Biotechnologies Ltd
CLGNAdd to Watchlist
0.340USD
-0.009-2.63%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.35MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-2.63%
5 Days
+2.25%
1 Month
-13.85%
6 Months
-77.01%
Year to Date
-75.70%
1 Year
-75.42%
Key Figures
0.380Open
0.380High
12.76KVolume
LossP/E TTM
1.76P/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
0.340Prev. Close
0.340Low
3.45KTurnover
LossP/E Static
0.47P/B
0.00%Div Yield TTM
-77.90%ROA
4.98052wk High
0.38Volume Ratio
-16.61MNet Profit
12.78MShares
-0.9415EPS TTM
0.92Beta
-117.56%ROE
0.49552wk Low
11.72%Amplitude
-332.88%Gross Margin
4.35MMarket Cap
-1.99Reward/Risk
6.96%Risk Rate
TradingKey Stock Score of Collplant Biotechnologies Ltd
Currency: USD Updated: 2026-07-02Key Insights
Collplant Biotechnologies Ltd's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 247 out of 387 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as , with the highest price target at 11.00.In the medium term, the stock price is expected to remain stable.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Collplant Biotechnologies Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative-
Collplant Biotechnologies Ltd Highlights
StrengthsRisks
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Growing
The company is in a growing phase, with the latest annual income totaling USD 2.37M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 2.37M.
Overvalued
The company’s latest PE is -0.36, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.89M shares, decreasing 10.36% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 21.95K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.38.
Analyst Rating
Based on
0
analysts
--
Current Rating
11.000
Target Price
+3132.44%
Upside Space
Collplant Biotechnologies Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Collplant Biotechnologies Ltd Info
CollPlant Biotechnologies Ltd, formerly known as Collplant Holdings Ltd, is a company dealing in aesthetic medicine and regenerative medicine based in Israel. The company provides products and technologies for broadly understood regenerative medicine, including tissue regeneration and organ production. The technology is based on plants and is based on the production of collagen type I (rhCollagen).
Ticker SymbolCLGN
CompanyCollplant Biotechnologies Ltd
CEORotem (Eran)
Websitehttps://www.collplant.com
Related Instruments
+1.62%
+3.50%
+6.14%
+3.96%
+3.31%
+3.72%
+3.55%
+3.40%
+4.21%
+1.80%
+6.03%
+4.11%
+4.62%
+3.68%
+2.35%
0.00%
+4.73%
+3.32%
+0.41%
+4.98%Popular Instruments
52852.900
+10.400 (+0.02%)
29669.900
+358.500 (+1.22%)
7507.800
+36.300 (+0.49%)
14963.000
+160.000 (+1.08%)
69676.000
+1528.000 (+2.24%)
6412.400
+59.600 (+0.94%)
68.683
+0.339 (+0.50%)
308.630
+14.250 (+4.84%)
194.830
-2.750 (-1.39%)
4174.610
+52.700 (+1.28%)
FAQs
What is the current price of Collplant Biotechnologies Ltd (CLGN)?
The current price of Collplant Biotechnologies Ltd (CLGN) is 0.34.
What is the symbol of Collplant Biotechnologies Ltd?
The ticker symbol of Collplant Biotechnologies Ltd is CLGN.
What is the 52-week high of Collplant Biotechnologies Ltd?
The 52-week high of Collplant Biotechnologies Ltd is 4.98.
What is the 52-week low of Collplant Biotechnologies Ltd?
The 52-week low of Collplant Biotechnologies Ltd is 0.49.
What is the market capitalization of Collplant Biotechnologies Ltd?
The market capitalization of Collplant Biotechnologies Ltd is 4.35M.
What is the Earnings Per Share (EPS TTM) of Collplant Biotechnologies Ltd (CLGN)?
The Earnings Per Share (EPS TTM) of Collplant Biotechnologies Ltd (CLGN) is -0.94.